Tumor type specific treatment in breast cancer

At international symposiums where international participation is high and about 20 lecturers share scientific developments Anatolia Health Center General Surgery Expert and Breast Center Manager Dr. Prof. Dr. Metin Çakmakçı as well as MD Anderson Cancer Center. Dr. Banu Arun, Florida Dr. Eleftherios P. Mamounas and Director of the Mannheim University Hospital Breast Center. Dr. In Marc Sütterlin, every year, 1 million 400 thousand women are witnessed breast cancer and shared the new treatment methods with the participants.

Oncological Sciences Symposium, organized by Anadolu Medical Center in Turkey and abroad every year brings together for the sharing of important new developments in medicine physician. In this symposium, which was organized by the third year of this year and shared the experiences of about 20 speakers, Professor of General Surgery and Breast Center Manager from Anadolu Medical Center. Dr. Metin Çakmakçı, Professor at MD Anderson Cancer Center. Dr. Dr. Banu Arun, Dr. at the University of Florida Cancer Center. Eleftherios P. Mamounas and Director of Breast Center at Mannheim University Hospital. Dr. Marc Sütterlin breast cancer treatment what the stamp will tell the latest developments.

I do not scare the breast cancer after all the complications

Noting that breast cancer is the most common type of cancer in women, Prof. Dr. Metin Çakmakçı, "There are a lot of researches about breast cancer. There are many developments in both diagnosis and treatment methods. According to the types of breast cancer treatment options are becoming different day by day, and private treatment is the forefront. "

Professor Dr. Lighter says breast cancer has become a form of cancer that does not frighten her when conscious behaviors, such as better recognition of breast structures, awareness of changes in her breasts, and yearly breast scan, when combined with modern medical technology.

Genetic factors affect 10% of breast cancers

Professor Dr. Banu Arun, "We look at whether there is a genetic factor that causes this disease in the family of our early breast cancer patients. About 10 percent of breast cancers are due to genetic factors. 85 percent of these are due to mutations in genes called BRCA1, BRCA2. In the appropriate patient, we are looking at whether this genetic mutation is kanda. If this mutation is present, we know that the risk of breast cancer and the risk of ovarian cancer are very high.

Accordingly, we recommend early screening, and sometimes some approaches to prevent disease with surgery. This is of course a very personal decision, we are discussing with patients, we certainly do not need to undergo surgery. But at least they know that the risk is high. They are starting to scan early, and some people think that surgery is better suited for them, and they refer to procedures such as mastectomy for prevention (removal of the mammary gland) and removal of the ovaries to prevent ovarian cancer. "

'Neo-adjuvant chemotherapy' can shrink the tumor

In the last 10 years, many cancer treatments, such as breast cancer, said that the brand new drugs were developed at the University of Florida Cancer Center. Eleftherios P. Mamounas, "We have new approaches to treatment and new drugs we use especially in early breast cancer. Our treatment approach is now personal, targeted. It is important that we can specify subgroups, types of tumor so that we can do this. We treat patients according to their genetic characteristics and tumor type.

For example, before the breast surgery 'Neo-adjuvant chemotherapy' we prefer to apply chemotherapy. Thanks to this chemotherapy given to reduce the tumor, the patient is saved from a bigger surgery and if we take the whole breast through surgery, we only get that small mass. We also give the patient less radiation therapy after the surgery, "he says.

Radiotherapy during surgery is accelerating the process

Director of the Breast Center at Mannheim University Hospital. Dr. Marc Sütterlin said, "One of the new techniques in breast cancer and treatment is to give radiotherapy during surgery. With this method, some medical benefits can be provided by giving the patient time. Normally, a surgery is performed to remove the tumor before breast cancer surgery, followed by radiation therapy for several weeks.

However, in the option of intraoperative radiotherapy; Radiotherapy is given immediately after the tumor is removed during surgery. Thus, the 5-week treatment of radiotherapy is completed in only 30-40 minutes, "he says. Noting that this treatment method can not be applied to all patients, Prof. Dr. Sütterlin says that if the tumor is too large and the cavity to be left after the tumor is large, then this method can not be applied and other criteria are also important.